Kato Ayumu, Go Tetsuhiko, Otsuki Yasuhiro, Yokota Naoya, Soo Chang Sung, Misaki Noriyuki, Yajima Toshiki, Yokomise Hiroyasu
Department of General Thoracic, Breast and Endocrine Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Front Surg. 2023 Jan 12;9:1089403. doi: 10.3389/fsurg.2022.1089403. eCollection 2022.
The availability of clinically applied medical materials in thoracic surgery remains insufficient, especially materials for treating tracheal defects. Herein, the potential of porcine extracellular matrix (P-ECM) as a new airway reconstruction material was explored by xenotransplanting it into a canine trachea.
P-ECM was first transplanted into the buttocks of Narc Beagle dogs ( = 3) and its overall immuno-induced effects were evaluated. Subsequently, nine dogs underwent surgery to create a tracheal defect that was 1 × 2 cm. In group A, the P-ECM was implanted parallel to the tracheal axis ( = 3), whereas in group B the P-ECM was implanted perpendicular to the tracheal axis ( = 6). The grafts were periodically observed by bronchoscopy and evaluated postoperatively at 1 and 3 months through macroscopic and microscopic examinations. Immunosuppressants were not administered. Statistical evaluation was performed for Bronchoscopic stenosis rate, graft epithelialization rate, shrinkage rate and ECM live-implantation rate.
No sign of P-ECM rejection was observed after its implantation in the buttocks. Bronchoscopic findings showed no improvement concerning stenosis in group A until 3 months after surgery; epithelialization of the graft site was not evident, and the ECM site appeared scarred and faded. In contrast, stenosis gradually improved in group B, with continuous epithelium within the host tissues and P-ECM. Histologically, the graft site contracted longitudinally and no epithelialization was observed in group A, whereas full epithelialization was observed on the P-ECM in group B. No sign of cartilage regeneration was confirmed in both groups. No statistically significant differences were found in bronchoscopic stenosis rate, shrinkage rate and ECM live-implantation rate, but graft epithelialization rate showed a statistically significant difference (G-A; sporadic (25%) 3, vs. G-B; full covered (100%) 3; = 0.047).
P-ECM can support full re-epithelialization without chondrocyte regeneration, with perpendicular implantation facilitating epithelialization of the ECM. Our results showed that our decellularized tracheal matrix holds clinical potential as a biological xenogeneic material for airway defect repair.
胸外科临床应用的医用材料仍然不足,尤其是治疗气管缺损的材料。在此,通过将猪细胞外基质(P-ECM)异种移植到犬气管中,探索其作为新型气道重建材料的潜力。
首先将P-ECM移植到麻醉的比格犬(n = 3)的臀部,评估其整体免疫诱导作用。随后,9只犬接受手术制造1×2 cm的气管缺损。A组(n = 3)将P-ECM平行于气管轴植入,而B组(n = 6)将P-ECM垂直于气管轴植入。定期通过支气管镜观察移植物,并在术后1个月和3个月通过宏观和微观检查进行评估。未给予免疫抑制剂。对支气管镜狭窄率、移植物上皮化率、收缩率和ECM活植入率进行统计学评估。
P-ECM植入臀部后未观察到排斥迹象。支气管镜检查结果显示,A组直到术后3个月狭窄情况均无改善;移植物部位上皮化不明显,ECM部位出现瘢痕化和褪色。相比之下,B组狭窄逐渐改善,宿主组织和P-ECM内有连续上皮。组织学上,A组移植物部位纵向收缩,未观察到上皮化,而B组P-ECM上观察到完全上皮化。两组均未确认有软骨再生迹象。支气管镜狭窄率、收缩率和ECM活植入率无统计学显著差异,但移植物上皮化率有统计学显著差异(A组;散在(25%)3例, vs. B组;完全覆盖(100%)3例;P = 0.047)。
P-ECM可支持完全重新上皮化而无软骨细胞再生,垂直植入有利于ECM上皮化。我们的结果表明,我们的去细胞气管基质作为气道缺损修复的生物异种材料具有临床潜力。